Glenmark Pharmaceuticals informs about press release
Date: 06-09-2016Glenmark Pharmaceuticals has informed about a Press Release dated September 06, 2016 titled ‘Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel Bispecific Monoclonal Antibody targeting EGFR’.
The above information is a part of company’s filings submitted to BSE.